Second heartbeat
BEIJING, Aug. 13, 2025 /PRNewswire/ -- A news report from chinadaily.com.cn In this documentary, three patients suffered from advanced heart failure share their stories of how China's independently-developed non-contact full maglev artificial heart brought hope to their lives. Click to learn more!
Ascletis Announces ASC47, a Muscle-Preserving Weight Loss Drug Candidate for Treatment of Obesity, Demonstrated Greater Efficacy with Tirzepatide than Semaglutide in a Preclinical Model
- The combination of ASC47 low dose with tirzepatide in diet-induced obese (DIO) mice resulted in an 87% greater reduction in body weight compared to tirzepatide monotherapy. - ASC47 low dose in combination with tirzepatide demonstrated statistically significantly greater increase in efficacy than ASC47 low dose in combination with semaglutide, 87%...
MindHYVE.ai Partners with ICS Pakistan and NEI Pakistan to Revolutionize Nursing Education with AI-Powered ArthurAI
ISLAMABAD, Aug. 13, 2025 /PRNewswire/ --In a pioneering step towards elevating nursing education in Pakistan, MindHYVE.ai has signed strategic Memorandum of Understanding (MoU) with the Institute of Contemporary Studies (ICS) and the National Excellence Institute (NEI). MindHYVE.ai, ICS, and NEI Forge Partnership to Revolutionize Nursing Education in Pakistan with...
VivaVision Strengthens Scientific Advisory Board with a World-Renowned Expert in Ophthalmology
WENZHOU, China, Aug. 13, 2025 /PRNewswire/ -- Recently, VivaVision Biotech (Zhejiang) Co., Ltd. (VivaVision) announced the appointment of Quan Dong Nguyen, MD, MSc, FAAO, FARVO, FASRS to its Scientific Advisory Board. Quan Dong Nguyen, MD, MSc, FAAO, FARVO, FASRS, is currently a professor of ophthalmology at the Byers Eye Institute, Stanford University School of Medicine; he is also a professor...
Mabwell Announces First Patient Dosed in the US Clinical Study of Bulumtatug Fuvedotin in TNBC Patients Previously Treated with ADCs
SHANGHAI, Aug. 12, 2025 /PRNewswire/ -- Mabwell (688062.SH), an innovative biopharmaceutical company with entire industry chain, announced the first patient dosing in the U.S. for a clinical study of its novel nectin-4-targeting antibody-drug conjugate (Bulumtatug Fuvedotin, or BFv, R&D code: 9MW2821) in triple-negative breast cancer (TNBC) patients previously treated with antibody-drug conjugate (ADC). This is the first overseas clinical...
Aquedeon Medical Inc. Receives FDA Approval to Expand Clinical Trial of Duett Vascular Graft System
CAUTION: Investigational device. Limited by Federal (or United States) law to investigational use. SUNNYVALE, Calif., Aug. 12, 2025 /PRNewswire/ -- Aquedeon Medical Inc. (AMI) is pleased to announce that the U.S. Food and Drug Administration (FDA) has approved the expansion of its Investigational Device Exemption (IDE) clinical trial evaluating the Duett Vascular Graft System (Duett System), a novel...
Manipal Hospitals Kolkata completes 50 successful TAVR cases
KOLKATA, India, Aug. 12, 2025 /PRNewswire/ -- Manipal Hospitals - EM Bypass (erstwhile Medica Superspecialty Hospital), Kolkata is thrilled to announce the completion of 50 successful Transcatheter Aortic Valve Replacement (TAVR) cases, establishing the facility as a regional market leader in structural cardiac procedures in Eastern India. TAVR is a minimally invasive approach of...
WuXi Biologics’ WuXiUP™ Accomplishes Automated Continuous Drug Substance Production at Pilot-Scale
Building on its success in developing continuous production at pilot-scale with the WuXiUP™ platform, WuXi Biologics has further enhanced the technology to achieve automated continuous drug substance (DS) manufacturing at pilot-scale. This advancement integrates industry-leading technologies, including membrane chromatography and automated control systems, along with iterative enhancements to Process Analytical Technology (PAT). The WuXiUP™ automated continuous production platform will deliver...
For everyone with sensitive skin: Understanding skin science with Cetaphil and its new innovative product
KUALA LUMPUR, Malaysia, Aug. 12, 2025 /PRNewswire/ -- Cetaphil®, the trusted global leader in sensitive skincare and the No. 1 dermatological skincare brand in Malaysia*, announced a transformative rebrand with a bold shift towards an advocacy-first strategy. This new approach was unveiled at the inaugural Cetaphil SkinLABS launch and is built upon Cetaphil's ongoing collaboration with dermatologists, while also...
Life (Insurance) starts at 30 – when Aussies wish they’d signed up for coverage
BRISBANE, Australia, Aug. 12, 2025 /PRNewswire/ -- One quarter of Australians with life insurance wish they'd taken out their policy earlier in life, according to a new Budget Direct Life Insurance survey. The poll of 997 Australians with life insurance also reveals the age they recommend signing up. Around 39% of people surveyed felt the best time to invest...
